This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer
Dr. William Sanchez discusses his manuscript "Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis."
No comments:
Post a Comment